✦ LIBER ✦

Mibefradil, a potent CYP3A inhibitor, does not alter pravastatin pharmacokinetics

✍ Scribed by Laurent Becquemont; Christian Funck-Brentano; Patrice Jaillon

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Saxagliptin, a potent, selective inhibit

✍ C. G. Patel; D. Kornhauser; N. Vachharajani; B. Komoroski; E. Brenner; M. Handsc 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 728 KB

Pravastatin, a 3-hydroxy-3-methyl-glutha

✍ Przemyslaw J. Kotyla 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 112 KB

Clotrimazole, but not dexamethasone, is

✍ Burkina, Viktoriia; Zlabek, Vladimir; Zamaratskaia, Galia 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 597 KB

Concomitant administration of the α-gluc

✍ P. Kleist; A. Ehrlich; Y. Suzuki; W. Timmer; N. Wetzelsberger; P. W. Lücker; H. 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 139 KB

Sitagliptin, an dipeptidyl peptidase-4 i

✍ Goutam C. Mistry; Arthur J. Bergman; Wei Zheng; David Hreniuk; Miguel A. Zinny; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

Inhibition of CYP3A4 does not influence

✍ Jannuzzo, M.G.; Spinelli, R.; Poggesi, I.; Cicioni, P.; Böttiger, Y.; Bertilsson 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 135 KB